Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Phenoxybenzamine [PBZ] IV to Assist High Flow Low Pressure Perfusion [HFLPP] on Cardio-pulmonary Bypass in Infants and Children With Congenital Heart Disease and to Assist Steady State Alfa-blockade in the Intensive Care Phase

NCT00620945 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT00620945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00620945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Phenoxybenzamine [PBZ] IV to Assist High Flow Low Pressure Perfusion [HFLPP] on Cardio-pulmonary Bypass in Infants and Children With Congenital Heart Disease and to Assist Steady State Alfa-blockade in the Intensive Care Phase
Lead sponsor
The Cleveland Clinic
Phase
Not applicable
Overall status
Terminated
Start date
June 30, 2006
Completion date
February 28, 2009
Enrollment
87 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiopulmonary bypass, congenital heart surgery